$403 Million is the total value of Ally Bridge Group (NY) LLC's 29 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDVL | MEDAVAIL HOLDINGS INC | $35,780,000 | -12.5% | 2,920,780 | 0.0% | 8.89% | +13.4% | |
| NTRA | NATERA INC | $24,750,000 | +11.8% | 218,000 | 0.0% | 6.15% | +44.9% | |
| FATE | FATE THERAPEUTICS INC | $23,433,000 | +5.3% | 270,000 | 0.0% | 5.82% | +36.4% | |
| RGEN | REPLIGEN CORP | $16,469,000 | +2.7% | 82,500 | 0.0% | 4.09% | +33.0% | |
| COGT | COGENT BIOSCIENCES INC | $13,159,000 | -7.6% | 1,622,591 | 0.0% | 3.27% | +19.7% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $10,590,000 | -17.8% | 406,986 | 0.0% | 2.63% | +6.5% | |
| EPIX | ESSA PHARMA INC | $10,376,000 | -1.7% | 363,185 | 0.0% | 2.58% | +27.4% | |
| ACET | ADICET BIO INC | $4,373,000 | -21.3% | 425,000 | 0.0% | 1.09% | +1.9% | |
| SBTX | SILVERBACK THERAPEUTICS INC | $3,972,000 | -29.2% | 128,572 | 0.0% | 0.99% | -8.3% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Fan Yu #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDAVAIL HOLDINGS INC | 11 | Q2 2023 | 8.9% |
| UNUM THERAPEUTICS INC | 8 | Q3 2022 | 7.3% |
| RAPID MICRO BIOSYSTEMS INC-A | 8 | Q2 2023 | 3.5% |
| FATE THERAPEUTICS INC | 7 | Q2 2022 | 5.8% |
| VIRIDIAN THERAPEUTICS INC | 7 | Q2 2023 | 6.8% |
| SYROS PHARMACEUTICALS INC | 7 | Q2 2022 | 4.9% |
| REPLIGEN CORP | 7 | Q4 2022 | 6.5% |
| NAUTILUS BIOTECHNOLOGY INC | 7 | Q4 2022 | 3.8% |
| ARVINAS INC | 6 | Q1 2022 | 7.5% |
| NUVATION BIO INC | 6 | Q2 2022 | 4.9% |
View Ally Bridge Group (NY) LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | November 19, 2020 | 1,420,500 | 8.0% |
View Ally Bridge Group (NY) LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-06-21 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-03-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Ally Bridge Group (NY) LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.